GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurobiological Technologies Inc (OTCPK:NTII) » Definitions » Scaled Net Operating Assets

Neurobiological Technologies (Neurobiological Technologies) Scaled Net Operating Assets : 0.11 (As of Sep. 2009)


View and export this data going back to 1994. Start your Free Trial

What is Neurobiological Technologies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Neurobiological Technologies's operating assets for the quarter that ended in Sep. 2009 was $3.29 Mil. Neurobiological Technologies's operating liabilities for the quarter that ended in Sep. 2009 was $0.66 Mil. Neurobiological Technologies's Total Assets for the quarter that ended in Jun. 2009 was $24.66 Mil. Therefore, Neurobiological Technologies's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2009 was 0.11.


Neurobiological Technologies Scaled Net Operating Assets Historical Data

The historical data trend for Neurobiological Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurobiological Technologies Scaled Net Operating Assets Chart

Neurobiological Technologies Annual Data
Trend Jun00 Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.12 -2.72 -1.38 -0.89 -0.01

Neurobiological Technologies Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.25 -0.38 -0.41 -0.02 0.11

Competitive Comparison of Neurobiological Technologies's Scaled Net Operating Assets

For the Biotechnology subindustry, Neurobiological Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurobiological Technologies's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Scaled Net Operating Assets falls into.



Neurobiological Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Neurobiological Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Jun. 2009 is calculated as

Scaled Net Operating Assets (SNOA)(A: Jun. 2009 )
=(Operating Assets (A: Jun. 2009 )-Operating Liabilities (A: Jun. 2009 ))/Total Assets (A: Jun. 2008 )
=(0.611-1.115)/43.187
=-0.01

where

Operating Assets(A: Jun. 2009 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=24.66 - 24.049
=0.611

Operating Liabilities(A: Jun. 2009 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1.115 - 0 - 0
=1.115

Neurobiological Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2009 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2009 )
=(Operating Assets (Q: Sep. 2009 )-Operating Liabilities (Q: Sep. 2009 ))/Total Assets (Q: Jun. 2009 )
=(3.293-0.655)/24.66
=0.11

where

Operating Assets(Q: Sep. 2009 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=29.782 - 26.489
=3.293

Operating Liabilities(Q: Sep. 2009 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.655 - 0 - 0
=0.655

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurobiological Technologies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurobiological Technologies (Neurobiological Technologies) Business Description

Traded in Other Exchanges
N/A
Address
2010 Crow Canyon Place, Suite 100, San Ramon, CA, USA, 94583
Neurobiological Technologies Inc is a biopharmaceutical company historically focused on developing investigational drugs for central nervous system conditions.
Executives
Ariel Warszawski 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Ryan Heslop 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Firefly Management Co Gp, Llc 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Fvp Gp, Llc 10 percent owner C/O FIREFLY VALUE PARTNERS, LP, 551 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10176
Firefly Value Partners, Lp 10 percent owner 426 PINEVILLE ROAD, UNIT 1, NEWTOWN PA 18940
Fvp Master Fund Lp 10 percent owner FVP GP LLC, 551 FIFTH AVENUE, 36TH FLOOR, New York NY 10176
John B Stuppin director
Abraham E Cohen director 500 SEVENTH AVE 10TH FL, C/O AXONYX INC, NEW YORK NY 10018
Abraham D Sofaer director HOOVER INSTITUTION, STANFORD UNIVERSITY, STANFORD CA 94305-6010
Biotechnology Value Fund L P other: Direct Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Partners L P/il 10 percent owner 44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Inc/il 10 percent owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Biotechnology Value Fund Ii Lp other: Direct Beneficial Owner 44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Investments Llc other: Direct Beneficial Owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104
Mark N Lampert 10 percent owner 1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104

Neurobiological Technologies (Neurobiological Technologies) Headlines